Axsome Therapeutics Stock Rises 36% In A Month But Will The Rally Continue?
- Monday, September 20, 2021, 7:15
- Market
- Add a comment
A couple of months back we discussed that Axsome Therapeutics stock is likely to rebound after it fell nearly 20% in a month following the U.S. FDA’s decision to pull the breakthrough therapy designation of AXS-12, the company’s drug used for the treatment of narcolepsy…
About the Author
admin123 has written 23527 stories on this site.
